Literature DB >> 25418518

To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?

Xia Jiang1, Thomas Frisell, Johan Askling, Elizabeth W Karlson, Lars Klareskog, Lars Alfredsson, Henrik Källberg.   

Abstract

OBJECTIVE: Family history of rheumatoid arthritis (RA) is one of the strongest risk factors for developing RA, and information on family history is, therefore, routinely collected in clinical practice. However, as more genetic and environmental risk factors shared by relatives are identified, the importance of family history may diminish. The aim of this study was to determine how much of the familial risk of RA can be explained by established genetic and nongenetic risk factors.
METHODS: History of RA among first-degree relatives of individuals in the Epidemiological Investigation of Rheumatoid Arthritis case-control study was assessed through linkage to the Swedish Multigeneration Register and the Swedish Patient Register. We used logistic regression models to investigate the decrease in familial risk after successive adjustment for combinations of nongenetic risk factors (smoking, alcohol intake, parity, silica exposure, body mass index, fatty fish consumption, and education), and genetic risk factors (shared epitope [SE] and 76 single-nucleotide polymorphisms [SNPs]).
RESULTS: Established nongenetic risk factors did not explain familial risk of either seropositive or seronegative RA to any significant degree. Genetic risk factors accounted for a limited proportion of the familial risk of seropositive RA (unadjusted odds ratio [OR] 4.10, SE-adjusted OR 3.72, SNP-adjusted OR 3.46, and SE and SNP-adjusted OR 3.35).
CONCLUSION: Established risk factors only provided an explanation for familial risk of RA in minor part, suggesting that many (familial) risk factors remain to be identified, in particular for seronegative RA. Family history of RA therefore remains an important clinical risk factor for RA, the value of which has not yet been superseded by other information. There is thus a need for further etiologic studies of both seropositive and seronegative RA.
Copyright © 2015 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25418518     DOI: 10.1002/art.38927

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  15 in total

1.  Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested Cyclic Citrullinated Peptide Antibody-Positive Patients Without Rheumatoid Arthritis.

Authors:  Julia A Ford; Xinyi Liu; Allison A Marshall; Alessandra Zaccardelli; Maria G Prado; Charlene Wiyarand; Bing Lu; Elizabeth W Karlson; Peter H Schur; Kevin D Deane; Jeffrey A Sparks
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-12       Impact factor: 4.794

Review 2.  Family history of rheumatoid arthritis: an old concept with new developments.

Authors:  Thomas Frisell; Saedis Saevarsdottir; Johan Askling
Journal:  Nat Rev Rheumatol       Date:  2016-04-21       Impact factor: 20.543

Review 3.  Genetic and environmental risk factors for rheumatoid arthritis.

Authors:  Kevin D Deane; M Kristen Demoruelle; Lindsay B Kelmenson; Kristine A Kuhn; Jill M Norris; V Michael Holers
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-09-18       Impact factor: 4.098

Review 4.  Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis.

Authors:  Alexander Kalinkovich; Gulzan Gabdulina; Gregory Livshits
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

5.  Associations of Smoking and Age With Inflammatory Joint Signs Among Unaffected First-Degree Relatives of Rheumatoid Arthritis Patients: Results From Studies of the Etiology of Rheumatoid Arthritis.

Authors:  Jeffrey A Sparks; Shun-Chiao Chang; Kevin D Deane; Ryan W Gan; M Kristen Demoruelle; Marie L Feser; LauraKay Moss; Jane H Buckner; Richard M Keating; Karen H Costenbader; Peter K Gregersen; Michael H Weisman; Ted R Mikuls; James R O'Dell; V Michael Holers; Jill M Norris; Elizabeth W Karlson
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

6.  Immune responses to Mycobacterial heat shock protein 70 accompany self-reactivity to human BiP in rheumatoid arthritis.

Authors:  Hirofumi Shoda; Norio Hanata; Shuji Sumitomo; Tomohisa Okamura; Keishi Fujio; Kazuhiko Yamamoto
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

7.  A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study.

Authors:  Xia Jiang; Johan Askling; Saedis Saevarsdottir; Leonid Padyukov; Lars Alfredsson; Sebastien Viatte; Thomas Frisell
Journal:  Arthritis Res Ther       Date:  2016-12-03       Impact factor: 5.156

Review 8.  Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

Authors:  Kevin Didier; Loïs Bolko; Delphine Giusti; Segolene Toquet; Ailsa Robbins; Frank Antonicelli; Amelie Servettaz
Journal:  Front Immunol       Date:  2018-03-26       Impact factor: 7.561

9.  Family History of Rheumatic, Autoimmune, and Nonautoimmune Diseases and Risk of Rheumatoid Arthritis.

Authors:  Vanessa L Kronzer; Cynthia S Crowson; Jeffrey A Sparks; Elena Myasoedova; John Davis
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-02       Impact factor: 4.794

10.  Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis.

Authors:  Ryan W Gan; M Kristen Demoruelle; Kevin D Deane; Michael H Weisman; Jane H Buckner; Peter K Gregersen; Ted R Mikuls; James R O'Dell; Richard M Keating; Tasha E Fingerlin; Gary O Zerbe; Michael J Clare-Salzler; V Michael Holers; Jill M Norris
Journal:  Ann Rheum Dis       Date:  2016-05-17       Impact factor: 27.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.